The AIDS immunoblastic lymphoma cell line (IBL1) and the LCL were overall less responsive to both HDAC inhibitors and were more sensitive to cell cycle arrest and cell death, particularly following treatment with panobinostat. This evidence concerns the gene HDAC9 and AIDS.